Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

April 10, 2021

Primary Completion Date

November 14, 2026

Study Completion Date

November 14, 2026

Conditions

Hematopoietic and Lymphoid Cell Neoplasm

Interventions

OTHER

Data Capture

Treatment related data is collected

OTHER

Electronic Medical Record

Medical records are reviewed

Trial Locations (1)

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors

lead

M.D. Anderson Cancer Center

OTHER